| Description | Alendronic Acid (alendronate) is a nonhormonal medication used for osteoporosis, osteogenesis imperfecta, and several other bone diseases. |
| In vivo | Alendronic Acid in the treatment of osteoporosis in children and adolescents[1]. |
| Synonyms | alendronate, 阿仑膦酸 |
| molecular weight | 249.1 |
| Molecular formula | C4H13NO7P2 |
| CAS | 66376-36-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| Solubility | DMSO: < 1 mg/mL (insoluble） H2O: 5 mg/mL |
| References | 1. Martín Siguero A, Áreas Del Águila VL, Franco Sereno M T , et al. Efficacy and safety of alendronic acid in the treatment of osteoporosis in children.[J]. Farm Hosp, 2015, 39(6):350-354. 2. Parente-Pereira A C , Shmeeda H , Whilding L M , et al. Adoptive Immunotherapy of Epithelial Ovarian Cancer with V?9V?2 T Cells, Potentiated by Liposomal Alendronic Acid[J]. The Journal of Immunology, 2014, 193(11):5557-5566. |